Participate in our colorectal cancer clinical trials and contribute to a pioneering research study for colon cancer.
Colorectal Cancer Clinical Trials
Emerging Future Treatment Options for Colorectal Cancer through Clinical Trials in Nebraska
Colorectal cancer (CRC) develops in the colon or rectum as abnormal cells grow in areas essential for digestion and waste removal. Symptoms may include changes in bowel habits, abdominal pain, rectal bleeding, unexplained weight loss, or persistent fatigue—signs that can interfere with daily comfort and overall health. NHO Revive Clinical Research is conducting a clinical trial evaluating an investigational therapy to determine whether it may offer benefits beyond current treatment options for individuals diagnosed with colorectal cancer.
By participating in this study, you support vital research that may help advance earlier detection tools, improve treatment strategies and enhance supportive care for people facing colorectal cancer.
Eligibility Criteria for Colorectal Cancer Research Studies
- Age: 18 years or older
- Gender: Both Male & Female
- Expected life expectancy >6 months
- Has received no other prior systemic therapy for metastatic CRC
*Participation in our clinical study is voluntary, and it’s important to consult with your healthcare provider before making any decisions related to your treatment or care.
*Participation in the clinical trials causes no expenses for you or your private medical insurance. You’ll receive compensation for your time and travel.
Status - Recruiting
About Symptoms of Colorectal Cancer and More
Colorectal cancer (CRC) affects the colon or rectum and remains one of the most common and serious cancers worldwide. In many cases, early colorectal cancer produces no symptoms, which is why screening is so important. When symptoms do appear, they may include changes in bowel habits (such as diarrhea, constipation, or narrower stools), blood or dark/ tar-like material in stool (rectal bleeding), persistent abdominal discomfort or cramps, unexplained weight loss, fatigue, or iron-deficiency anemia. Because early detection greatly improves outcomes with early-stage cancer, often having a high five-year survival rate — screening and prompt evaluation of warning signs are essential.
By participating in colorectal cancer research studies, you support critical efforts to improve early diagnosis, develop new treatments, and enhance care for patients — paving the way toward better health outcomes for individuals affected by colorectal cancer.
Get Started
What to Expect
If you volunteer for NHO Revive clinical trial by completing the form above, our study team will reach out to assess your eligibility for this breast cancer clinical trial. They’ll review the study specifics with you to check if you meet the criteria for participation. If you qualify, you’ll be invited to the study site for screening, located within a 50-mile radius of where you are now.
The doctors will discuss the trial’s duration and its impact on your cancer treatment. Once everything is explained, participants will be asked to sign an informed consent form. Make sure to go through everything with your provider. We value transparency between our participants and investigators.
*You’ll receive study-related care at no cost, including comprehensive physical exams and evaluations conducted by skilled clinicians.
Age
18 years and older
Gender
Both Male & Female
Location
New Bedford, MA
300
Certificated Physicians in +20 States.
About Disease
Risk Factors for Individuals with Colorectal Cancer
Although the exact cause of colorectal cancer is not fully understood, several factors are known to increase risk. These include older age, a personal or family history of colorectal cancer or polyps, and inherited conditions such as Lynch syndrome or FAP. Lifestyle factors like obesity, physical inactivity, smoking, heavy alcohol use, and diets high in red or processed meats also contribute, as do chronic inflammatory bowel diseases like Crohn’s disease or ulcerative colitis. Understanding these risk factors encourages timely screening and informed discussions with healthcare providers about prevention and early detection.
Frequently Asked Questions
Interested in learning more about our research? Explore our frequently asked questions to gain knowledge about this condition.
What are Clinical Trials for Colorectal Cancer?
Clinical trials for colorectal cancer are research studies that evaluate new investigational treatments, diagnostic methods, or supportive care approaches. These studies aim to determine whether emerging therapies may be safer, more effective, or better tolerated than current standard care options.
Who can participate in Colorectal Cancer Investigational Treatment?
Adults diagnosed with colorectal cancer may be eligible to participate. Each study has specific criteria, and a screening process is conducted by the research team to determine if a participant meets the necessary requirements.
How long does a Colorectal Cancer clinical trial last?
The duration of a colorectal cancer clinical trial varies depending on its design. Some may last a few months, while others may continue for a year or longer. The research team will outline the expected timeline, including treatment phases, follow-up appointments, and any long-term monitoring needed.
Are investigational treatments safe?
All investigational therapies undergo rigorous review and monitoring. Clinical trials follow strict FDA-regulated guidelines, and participants are closely observed for safety throughout the study. Any potential risks or side effects will be clearly explained during the consent process.
Can I leave a Colorectal Cancer clinical trial after I enroll?
Yes. Participation is voluntary, and you may withdraw from the study at any time for any reason. Leaving the trial will not affect your access to other available medical care or treatment options.
